Introduction
============

Average life expectancy has increased over the past century, resulting in a shift in world population demographics. Indeed, the number of elderly people is at its highest in human history. Previous research by McDermid and Bagshaw[@b1-cia-7-339] showed that comorbidity and dependency independently predicted mortality, and the need for hospitalization and institutionalization. As both comorbidity and dependency increase with age, more elderly people are living longer in more tenuous states of health. The proportion of elderly patients admitted to the hospital and intensive care is considerable compared with the general population, and data from the McDermid and Bagshaw study suggest an increasing trend in elderly admissions. A previously published study has shown that elderly patients often receive less intensive therapy and face greater support limitations when admitted to intensive care, implying that there may be a selection bias among elderly patients triaged for access to finite critical care.[@b1-cia-7-339] This may be due to the consumption of a disproportionate amount of the total intensive care unit (ICU), and total hospital, direct cost by the relatively small number of patients who require prolonged intensive care.[@b2-cia-7-339]

Most patients with an acute critical illness lack the capacity to make decisions about life-support treatments.[@b3-cia-7-339],[@b4-cia-7-339] Indeed, the majority of ICU deaths are preceded by such decisions, which may be based on documented pretreatment preferences regarding life-sustaining treatments that were previously expressed by the patient (as an advance directive), or the judgment of an appropriate surrogate decision maker, including a legally appointed, health-care proxy.[@b3-cia-7-339],[@b4-cia-7-339]

Against this background, this study aimed to evaluate the trends in intensive care treatment of very elderly patients. Specifically, this study attempted to verify whether there is an increase in intensive care treatments of the very elderly.

Methods
=======

Study groups
------------

A retrospective study was conducted on patients admitted into intensive care in the Department of Internal Medicine and the Department of Anesthesia, Intensive Care and Pain Management in the 400-bed Vinzentius-Hospital in Landau, Germany, from 2007 to 2011. The patients in the study group consisted of the very elderly (aged 90 and above) who were admitted into intensive care. These patients were compared against those between 80 and 89 years of age (control group) who were admitted into intensive care. All patients with primary internal diseases referred by family doctors, the emergency service center, and other medical departments were sampled.

Variables
---------

The demographics of both groups, such as age, sex, and reason for admission, were compared. Any secondary acute illnesses of the patients were grouped together according to organ systems, and compared. The cardiovascular risk factors examined were elevated blood pressure, diabetes mellitus, hyperlipidemia, obesity, smoking, and a family history of cardiovascular disease. Differences in comorbidities and length of stay in the ICU were also investigated. A major adverse cardiac event (MACE) was defined as the occurrence of death, a previous history of stroke, or myocardial infarction. The declaration of intent by all patients was considered prior to treatment in intensive care. If there was a written advance directive provided, the legal representative was again asked about the treatment in the intensive care units. For patients who were incapable of making a decision due to disease, a written request for the exhibition of an advance directive was made at the district court, after contacting a close family member. In cases of doubt, it was assumed that the patients would receive the full treatment in intensive care. The patients who refused treatment in the ICU, received full medical therapy in the general wards of the Department of Internal Medicine.

Statistical analysis
--------------------

The Chi-square test was used to make comparisons among variables such as gender, intensive care treatments, treatments conducted in the general wards of the internal departments of the hospital, medical emergency diseases, acute illnesses, cardiovascular risk factors, comorbidities, and MACE. The Mann--Whitney *U* test was used to calculate differences between the two groups in terms of the total number of intensive care treatments, length of stay in the ICU, total number of internal emergency diseases, acute illnesses, comorbidities, cardiovascular risk factors, and MACE. The confidence interval (CI) of a proportion was calculated as well. The survival rate for both groups was calculated using the Kaplan--Maier method. The data were checked for normality using the Kolmogorov--Smirnov test. A *P* value \< 0.05 was considered statistically significant. Results involving the mean and standard deviation (SD) are shown as "mean (SD)."

Results
=======

Intensive care treatments
-------------------------

A total of 8554 patients were sampled over the 5-year period, of whom 212 (2.48%) (95% CI, ±0.33%, 2.15%--2.81%) were in the study group and 1715 (20.05%) (95% CI, ±0.85%, 19.2%--20.9%) in the control group. A significant difference was found in the number of intensive care treatments between the two groups (*P* \< 0.001). As shown in [Figure 1](#f1-cia-7-339){ref-type="fig"}, the number of patients in both groups undergoing intensive care treatment remained relatively stable over the 5-year period, although a significant decline was observed in both groups in 2011. The number of people in the control group who received intensive care was consistently higher than that in the study group (n = 1539): 35 (2.27%) in the study group and 291 (18.91%) in the control group, in 2011.

Intensive care settings
-----------------------

The number of patients who received intensive care in the Department of Internal Medicine was 146 for the study group and 1121 in the control group, while the number of patients who received intensive care from the Department of Anesthesiology was 66 in the study group and 641 in the control group. A Chi-square test found no significant difference between the two medical settings in both groups (*P* = 0.13) ([Figure 2](#f2-cia-7-339){ref-type="fig"}).

General wards of the Department of Internal Medicine
----------------------------------------------------

The general wards of the Department of Internal Medicine treated (N = 20,996), 654 (3.11%) patients in the study group and 4968 (23.66%) from the control group during the 5-year period. There was a significant difference of hospital environment in both groups (*P* \< 0.0001); in other words, the type of ward that the patient was in (intensive care or general ward) significantly differed between the two groups ([Figure 3](#f3-cia-7-339){ref-type="fig"}).

Age and gender distribution
---------------------------

The mean age of all patients treated in intensive care was 66.41 (SD = 17.90) years, with the median and mode ages being 71 and 78 years, respectively. The mean ages of the study and control groups was 92.7 (SD = 6.98) and 83.84 (SD = 2.56) years, respectively. The median and mode ages in the study group were 92 and 91, respectively, and the median and mode ages in the control group were 84 and 81, respectively. The oldest patients (a man and a woman) were both aged 103. There was a significant difference for gender in treatment in intensive care (*P* \< 0.0011), with more women than men receiving intensive care in both groups ([Figure 4](#f4-cia-7-339){ref-type="fig"}).

Medical emergency diseases in the intensive care units
------------------------------------------------------

The two groups differed significantly in the total number of medical emergencies diagnosed (*P* \< 0.001), with more patients in the control group having a medical emergency than in the study group. However, a breakdown of the medical emergencies showed that significant differences between the two groups existed only in two types of emergencies -- cardiogenic pulmonary edema (*P* = 0.01) and acute respiratory failure (*P* = 0.02) -- with a higher proportion of patients in the study group treated for both of these emergencies compared with the control group. Acute respiratory failure and myocardial infarction were the most frequently occurring events for both groups ([Table 1](#t1-cia-7-339){ref-type="table"}).

Acute illnesses
---------------

A significant difference was found between the two groups in the total number of acute illnesses (*P* \< 0.01), with a larger number of patients in the control group being diagnosed with an acute illness than in the study group. A breakdown of the various acute illnesses revealed a significant difference between the two groups in thyroid illnesses (*P* = 0.046), nervous system disorders (*P* = 0.037), orthopedic conditions (*P* \< 0.01), and bone fractures (*P* \< 0.01). Cardiovascular and gastrointestinal diseases were diagnosed the most frequently for both groups ([Table 2](#t2-cia-7-339){ref-type="table"}).

Cardiovascular risk factors
---------------------------

The two study groups did not differ significantly in cardiovascular risk factors (*P* = 0.095). However, a breakdown of the risk factors found significant differences for each of the risk factors except nicotine habit (hypertension: *P* \< 0.01; diabetes: *P* \< 0.01; hyperlipidemia: *P* \< 0.01; obesity: *P* \< 0.01) ([Table 3](#t3-cia-7-339){ref-type="table"}).

Length of stay in the intensive care unit
-----------------------------------------

The average length of stay in the intensive care units was 4.73 (SD = 5.39) days in the study group and 5.68 (SD = 6.80) days in the control group. The Kolmogorov--Smirnov test showed that the normal distribution in the study and control groups was 70.339 and 589.956, respectively, with a significant deviation of at least 99% from a normal distribution. The length of the stay in the intensive care units did not differ significantly between the groups (*P* = 0.21).

Comorbidities
-------------

As shown in [Table 4](#t4-cia-7-339){ref-type="table"}, the two groups differed significantly in comorbidities (*P* \< 0.01), with more people in the control group having comorbidities compared with the study group. Significant differences between the two groups in the type of comorbidities present were also found (tumors: *P* \< 0.01; thyroid disorders: *P* \< 0.01; chronic ear, nose, and throat disorders: *P* = 0.03; ophthalmic disorders: *P* = 0.03). A higher proportion of patients in the study group had chronic ear, nose, and throat disorders and ophthalmic disorders as comorbid diseases than in the control group, whereas the proportion of people in the control group with tumors and thyroid disorders as comorbid diseases was higher than the study group. The most common comorbidities were disorders of the cardiovascular, renal, and gastrointestinal systems.

Major adverse cardiac event
---------------------------

In the study group, 10 patients (4.72%) had a history of stroke, while this number was 124 (7.23%) for the control group. There was no significant difference in this between the two groups (*P* = 0.175). The survival rate calculated using the Kaplan--Maier method for the 212 patients in the study group, where 3 (1.42%) deaths occurred, was 98.58% (95% CI, 96.98%--100%), while the calculated survival rate for patients in the control group, where 44 (2.57%) deaths occurred, was 97.43% (95% CI, 96.67%--98.19%). There was no significant difference between the two groups in the number of deaths (*P* = 0.31).

Discussion
==========

The increase in the proportion of elderly in the population has increased the demand for health care. Previous studies have shown that the number of patients aged 80 years and older admitted to the ICU has increased during the past decade, as has the intensity of the care for these patients.[@b5-cia-7-339] However, this study did not find an increase in the admissions of the elderly to the ICU. Indeed, significantly more patients (around 8 times as many), who were at least 10 years younger, were treated in the ICU. The failure to replicate the results of previous studies may be due to a number of reasons, such as life expectancy, the number of hospitals and available facilities for the elderly in the vicinity, and the existence of a geriatric department in the hospital. In the town where this study was conducted, there is another similar hospital. Facilities for elderly patients are available as well. For example, the hospital studied organizes the home care of single needy elderly before discharge. In addition, nursing homes for geriatric rehabilitation and even round-the-clock nurses are available, and could be hired to look after the patient at home. Furthermore, while this hospital lacks a geriatric department, clinics with geriatric departments are available in neighboring cities. These factors could have affected the size and parameters of the population in this study.

This study is also inconsistent with previous studies with regard to the gender distribution of patients treated in intensive care. While previous studies observed that men appear to be admitted more frequently than women among the elderly,[@b6-cia-7-339],[@b7-cia-7-339] the present study found that women were treated in intensive care more often than men, in both the study group and the control group. Although this does not correspond with most previous studies, the study conducted by Ngyuen et al[@b8-cia-7-339] provides a possible explanation for the current findings. The authors reviewed factors associated with prehospital delay in patients with acute myocardial infarction and found that women tended to delay seeking medical attention after developing possible symptoms. As delaying treatment increases the severity of the disease, and myocardial infarction was a frequently cited reason for hospital stay in the present study, this may have led to the current finding of more women being admitted to intensive care than men.

Discrepancies also exist between the young and the old in terms of delay of treatments and use of recommended guidelines. In a large review of elderly patients over 65 years who suffered from acute myocardial infarction, Nguyen et al[@b8-cia-7-339] reported that the elderly were more likely to have a longer prehospital delay than were younger patients. Although myocardial infarction was the second most predominant reason for intensive care admission in the present study, participants in the study group were still admitted less frequently than those in the control group. In contrast, the Nguyen et al study seems to imply that the very elderly were admitted more frequently than younger patients.

Intensive care admission criteria have traditionally included the severity of illness, comorbidities, the levels of frailty and disability, the expected impact of treatment on the outcome, the expression of wishes regarding do-not-resuscitate orders, and the availability of ICU beds.[@b9-cia-7-339] However, some data suggest that the presence of comorbidities and functional status may be poor predictors of outcome. In a large American cohort of elderly patients, Yende et al[@b10-cia-7-339] reported that prehospitalization comorbid conditions did not influence long-term mortality after pneumonia, although unplanned admission to the intensive care unit has been found to increase the risk of in-hospital mortality in very elderly patients.[@b11-cia-7-339] At least 50% of the risk of in-hospital death in this age group is attributable to a combination of unplanned admission and comorbidity with one or more disorders, such as acute renal failure and respiratory failure.[@b11-cia-7-339] This study found that the very elderly had no more comorbidities than the control group and that the survival rate of the very elderly was actually higher (although not significantly) than relatively younger patients. Even though the association between comorbidity and survival rate was not compared directly in this study, the results seem to imply that comorbidities do predict survival rate. Future studies could investigate the strength of the association between the different comorbidities and survival rates.

Recent data suggest that greater age and a high level of severity of illness are predictive of poor outcomes. Sligl et al[@b12-cia-7-339] reported that among critically ill adult patients with pneumonia, an age of 80 years and older was an independent predictor of death at 30 days, as well as one year. In this study, all patients, particularly those with pneumonia, with increasing respiratory failure or another indication for intubation, were transferred to the interdisciplinary intensive care setting for intubation. In the study group of the present study, one man and one woman (0.94%) died from pneumonia while nine men and seven women (0.93%) died from pneumonia in the control group. The survival rate for patients with pneumonia was slightly worse in the study group (99.06%) compared with the control group (99.07%) in the present study. The mortality rate for pneumonia was better in both groups in this study, than in the Sligl study.

This study observed that a relatively large number of the patients in the ICU had sepsis. Iwashyna et al[@b13-cia-7-339] demonstrated that severe sepsis was associated with cognitive impairment and functional disability, and severe sepsis patients exhibited a sharp decline in health-related quality of life during their intensive care stay followed by a gradual improvement during the 6 months after intensive care unit discharge,[@b14-cia-7-339] with recovery beginning after discharge from the ICU to the general ward. Nevertheless, recovery in physical functioning and general health dimensions at 6 months after intensive care unit discharge was incomplete, compared with preadmission status.[@b14-cia-7-339] Future studies could examine the outcome after admission to, or discharge from, the ICU, in terms of recovery instead of survival rate.

Injuries and illnesses leading to hospitalizations are associated with increased disability and reduced recovery.[@b15-cia-7-339] Indeed, in one study, a high mortality rate and a decrease in quality of life were observed in elderly patients with severe abdominal pathologies, although they were able to adapt well to their physical disabilities.[@b16-cia-7-339] The present study found that a large number of patients were admitted to the ICU because of gastrointestinal hemorrhage and acute pancreatitis. Although no investigation was conducted to determine changes in their levels of disabilities or quality of life, future studies could explore this aspect and verify the results of previous studies.

Yu et al[@b17-cia-7-339] found that the likelihood of an admission into the ICU among the elderly actually decreased with age, especially among those 85 years or older, with a great majority of them surviving at least 90 days.[@b17-cia-7-339] The authors suggested that the diagnostic mix is an important influence on ICU use by age.[@b17-cia-7-339] This is also a possible explanation for the failure to reveal an association between age and ICU admission in the present study. Future studies could investigate the effect of diagnostic mix on ICU admissions by age.

Conclusion
==========

The author did not observe an increase in the number of intensive care treatments of very elderly patients in the medical intensive care settings of the hospital studied in recent years. Indeed, the number of very elderly patients admitted into intensive care was lower than the number of patients who are relatively younger. The very elderly were also found to have less acute illnesses and comorbidities than relatively younger patients. In addition, more women than men were found to have received intensive care in both groups during the period in which this study was conducted.
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###### 

Number of medical cases admitted into intensive care by type

  **Medical cases**             **Number of cases**   **Number of cases %**   ***P*-value**     
  ----------------------------- --------------------- ----------------------- ----------------- -------------
  Acute coronary syndrome       16                    152                     7.02/9.71         0.52
  Myocardial infarction         43                    303                     18.86/19.36       0.35
  Shock                         11                    71                      4.82/4.54         0.48
  Syncope                       6                     76                      2.63/4.86         0.28
  Hypertensive crisis           10                    47                      4.39/3.00         0.11
  Cardiogenic pulmonary edema   27                    131                     11.84/8.37        \<0.01
  Septic shock                  13                    80                      5.70/5.11         0.35
  Acute respiratory failure     57                    345                     25.00/22.04       0.02
  Pulmonary embolism            2                     30                      0.88/1.92         0.32
  Decompensated cor pulmonale   4                     19                      1.75/1.21         0.37
  Severe infectious disease     10                    77                      4.39/4.92         0.88
  Intoxication                  2                     13                      0.88/0.83         0.77
  Gastrointestinal bleeding     11                    61                      4.82/3.90         0.24
  Epileptic attack              1                     36                      0.44/2.30         0.10
  Acute stroke                  15                    124                     6.58/7.92         0.93
  **Total cases (n = 1793)**    **228**               **1565**                **12.72/87.28**   **\<0.001**

###### 

Number of acute illnesses admitted into intensive care by type

  **Organ system**                           **Acute illnesses**                                                                                                                                                                                    **Number of cases**   **Study group (n = 612)/Control group (n = 5096) %**   ***P*-value**     
  ------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------- ------------------------------------------------------ ----------------- ------------
  Lung                                       Pneumonia                                                                                                                                                                                              30                    212                                                    4.90/4.16         0.39
  Cardiovascular system                      Heart rhythm disorders, acute heart failure, inflammatory heart disorders, vascular disorders, anemia, hypotension, venous thrombosis, acute hematological disorders                                   121                   1067                                                   19.77/20.94       0.50
  Respiratory system                         Acute dyspnea, asthma attack, infection and exacerbation of chronic obstructive pulmonary disease (COPD), pneumothorax, pleural effusion, pleuritis                                                    33                    206                                                    5.39/4.04         0.12
  Gastrointestinal system                    Acute abdomen, ileus, nausea, vomiting, acute diarrhea, reflux esophagitis, acute gastritis, acute pancreatitis, diverticulitis, gastroenteritis, ulcer, acute constipation, ascites, cholelithiasis   57                    538                                                    9.31/10.56        0.34
  Kidney diseases                            Acute renal failure, renal colic                                                                                                                                                                       19                    109                                                    3.10/2.14         0.13
  Thyroid illnesses                          Thyroid dysfunction                                                                                                                                                                                    4                     11                                                     0.65/0.22         0.046
  Water and electrolyte balance              Edema, exsiccosis, hypo- and hyperkalemia, hypo- and hypernatremia, acidosis, alkalosis, hypocalcemia, hyperuricemia                                                                                   91                    816                                                    14.87/16.01       0.46
  Urogenital system                          Acute urinary tract infection, hematuria, urosepsis, urinary retention                                                                                                                                 51                    329                                                    8.33/6.46         0.08
  Ear, nose, and throat disorders            Epistaxis, sinusitis, foreign body in larynx, hearing loss, stridor, cough, sialadenitis                                                                                                               1                     28                                                     0.16/0.55         0.20
  Diabetes                                   Hyperglycemia, coma diabeticum                                                                                                                                                                         3                     10                                                     0.49/0.20         0.15
                                             Hypoglycemic coma                                                                                                                                                                                      1                     4                                                      0.16/0.08         0.50
  Hypothermia                                                                                                                                                                                                                                       1                     5                                                      0.16/0.10         0.64
  Nervous system                             Acute and chronic neurological diseases, vertigo, headache, lumbago, tumor, Parkinson, polyneuropathy                                                                                                  26                    326                                                    4.25/6.40         0.037
  Psychiatry                                 Delirium, alcoholism, depression, panic, dementia                                                                                                                                                      80                    597                                                    13.07/11.72       0.33
  Dermatology                                Ulcers, decubitus ulcers, erysipelas, pruritus, wounds                                                                                                                                                 29                    210                                                    4.74/4.12         0.47
  Orthopedics: acute and chronic disorders   Osteomyelitis, arthritis, rheumatism, arthritis, osteoporosis, spondyloarthropathies, collagen diseases, vasculitis, degenerative vertebral column disorders                                           18                    348                                                    2.94/6.83         \<0.01
  Bone fractures                             Femoral, pelvis, radius, ulna, humerus, tibia, thoracic, lumbar vertebrae, ribs                                                                                                                        41                    219                                                    6.70/4.30         \<0.01
  Injury                                     Contusions                                                                                                                                                                                             6                     61                                                     0.98/1.20         0.64
  **Total cases (n = 5708)**                                                                                                                                                                                                                        **612**               **5096**                                               **10.72/89.28**   **\<0.01**

###### 

Number of cardiovascular risk factors in both groups by type

  **CVRF**                     **Study group (n = 212)**   **Control group (n = 1715)**   **Number of cases**   ***P*-value**
  ---------------------------- --------------------------- ------------------------------ --------------------- ---------------
  Hypertension                 93                          932                            58.86/50.00           \<0.01
  Diabetes                     45                          574                            28.48/30.79           \<0.01
  Hyperlipidemia               18                          264                            11.39/14.16           \<0.01
  Obesity                      2                           85                             1.27/4.56             \<0.01
  Nicotine habit               0                           9                              0.00/0.48             0.29
  **Total cases (n = 2022)**   **158**                     **1864**                       **7.81/92.19**        **0.095**

**Abbreviation:** CVRF, cardiovascular risk factors.

###### 

Comorbidities in both groups

  **Organ system**                         **Comorbidities**                                                                                                                                                                                                                                                      **Number of diagnosis**   **Number of diagnosis**   ***P*-value**    
  ---------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------- ------------------------- ---------------- ------------
  Cardiovascular system                    Coronary artery disease, congenital heart defects, cardiomyopathy, chronic heart failure, chronic cardiac arrhythmia, pacemaker therapy, congenital heart defects, peripheral arterial occlusive disease, varicosities, lymph edema, chronic hematological disorders   273                       2442                      54.38/49.88      0.055
  Respiratory system                       COPD, emphysema, pulmonary fibrosis, lung cancer, sleep apnea syndrome                                                                                                                                                                                                 17                        173                       3.39/3.53        0.86
  Gastrointestinal system                  Hiatal hernia, diverticula, gastrointestinal tumors, chronic gastrointestinal inflammatory disorders, polyps, liver cirrhosis, toxic liver damage, fecal incontinence                                                                                                  73                        686                       14.54/14.01      0.74
  Kidney diseases                          Chronic renal failure, glomerulonephritis, vascular renal disease, tubulointerstitial kidney disorders, malformations, renal tumors                                                                                                                                    90                        863                       17.93/17.63      0.87
  Urogenital system                        Urinary incontinence, chronic bladder and prostate disorders                                                                                                                                                                                                           19                        289                       3.78/5.90        0.051
  Thyroid illnesses                        Struma, thyroid carcinoma, Basedow disease, thyroiditis                                                                                                                                                                                                                6                         156                       1.20/3.19        0.01
  Oncology                                 Tumor diseases                                                                                                                                                                                                                                                         13                        247                       2.59/5.04        0.01
  Chronic ear, nose and throat disorders   Presbycusis, chronic sinusitis, head and neck cancer, chronic tinnitus                                                                                                                                                                                                 5                         17                        1.00/0.35        0.03
  Ophthalmology                            Cataract, glaucoma, macular degeneration, presbyopia                                                                                                                                                                                                                   6                         23                        1.20/0.47        0.03
  **Total diagnosis (n = 5398)**                                                                                                                                                                                                                                                                                  **502**                   **4896**                  **9.30/90.70**   **\<0.01**
